Uterine cancer in Jewish Israeli BRCA1/2 mutation carriers-Reference-Cited by-同舟云学术

Uterine cancer in Jewish Israeli BRCA1/2 mutation carriers

Published:2018-11-29 Issue:5 Volume:125 Page:698-703
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Laitman Yael¹,Michaelson‐Cohen Rachel²,Levi Einat²,Chen‐Shtoyerman Rakefet³,Reish Orit⁴,Josefsberg Ben‐Yehoshua Sagi³,Bernstein‐Molho Rinat⁵⁶,Keinan‐Boker Lital⁷⁸,Rosengarten Ora⁹,Silverman Barbara G.⁷,Perri Tamar¹⁰⁶,Korach Jacob¹⁰⁶,Mor Pnina²,Ephrat Ben‐Baruch Noa¹¹,Levy Lahad Ephrat²,Friedman Eitan¹⁶^ORCID,

Affiliation:

1. Oncogenetics Unit, Institute of Human Genetics, and Meirav High Risk Clinic, Chaim Sheba Medical Center Tel‐Hashomer Israel

2. Genetics Institute and NOGA High Risk Clinic, Shaare Zedek Medical Center, Hebrew University School of Medicine Jerusalem Israel

3. Oncogenetics Clinic, Clinical Genetics Institute, Kaplan Medical Center, Rehovot, Hebrew University School of Medicine Jerusalem Israel

4. Genetics Institute, Assaf Harofe Medical Center Zerifin Israel

5. Breast Cancer Unit, Oncology Institute, Chaim Sheba Medical Center Tel‐Hashomer Israel

6. Sackler School of Medicine Tel‐Aviv University Tel‐Aviv Israel

7. Israeli National Cancer Registry, Ministry of Health, Chaim Sheba Medical Center Tel‐Hashomer Israel

8. School of Public Health University of Haifa Haifa Israel

9. Gyneco‐Oncology Unit, Institute of Oncology, Shaare Zedek Medical Center, Hebrew University School of Medicine Jerusalem Israel

10. Department of Gyneco‐Oncology Sheba Medical Center Tel‐Hashomer Israel

11. Oncology Department Kaplan Medical Center, Rehovot, Hebrew University School of Medicine Jerusalem Israel

Funder

Israel Cancer Association

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.31842

Reference26 articles.

1. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

2. An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers

3. Cancer Incidence in BRCA1 Mutation Carriers

4. Cancer Risks in BRCA2 Mutation Carriers

5. The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BRCA 1/2 mutations and risk of uterine cancer: a systematic review and meta-analysis;BMC Genomic Data;2024-01-31

2. Down-regulation of FA-BRCA Pathway in Cervical Carcinoma Gradually Reversed During the Development of Chemo-tolerance: Clinical Implications;Reproductive Sciences;2023-11-27

3. Endometrial Cancer Risk Among Germline BRCA1/2 Pathogenic Variant Carriers: Review of Our Current Understanding and Next Steps;JCO Precision Oncology;2023-09

4. Genetic Analysis of Multiple Primary Malignant Tumors in Women with Breast and Ovarian Cancer;International Journal of Molecular Sciences;2023-04-04

5. Impact of the coverage of risk-reducing salpingo-oophorectomy by the national insurance system for women with BRCA pathogenic variants in Japan;Scientific Reports;2023-01-19